A randomIzed trial coMParing the ELUVIA dRug-elutIng stent versus Zilver PTX stent for treatment of superficiAL femoral and/or proximal popliteal arteries
A study for patients with Peripheral Artery Disease (PAD) using two of two drug-eluting stents
Sponsor: Boston Scientific
Enrolling: Male and Female Patients
IRB Number: AAAQ1404
U.S. Govt. ID: NCT02574481
Contact: Diana Catz: 212-342-4102 / dsc6@cumc.columbia.edu
Additional Study Information: The purpose of this research study is to compare the safety and effectiveness of two drug-eluting stents that are used to open the blocked or narrowed blood vessel of the leg in patients with Peripheral Artery Disease (PAD): the ELUVIA Stent and the Zilver PTX Stent.
This study is closed
Investigator
Danielle Bajakian, MD
Do You Qualify?
Have you been diagnosed with Peripheral Artery Disease (PAD)? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Diana Catz
dsc6@cumc.columbia.edu
212-342-4102
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE